Pfizer COVID Pills Highly Effective At Preventing Deaths; Suggests Trials

Pfizer on November 5, said that its experimental pill for COVID-19 reduced the rate of hospitalization and deaths of patients to nearly 90 percent. Reportedly, the drugmaker has recently joined in the race of making the world's first, easy consume medicine for Corona Virus in the United States. The company will be seeking approval from the FDA and international regulators for quick authorization.